Network Insights Methodology Whitepaper Get Access

Pfizer

PERSON Health Care / Pharmaceuticals Momentum 9.3ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$58B revenue (2025), New York-based Pfizer manufactures vaccines, oncology, and primary care drugs globally. Late-stage ADC lung cancer candidate failed clinical trial in June 2026, triggering strategic review of cancer portfolio; separately dismissed from multi-state antitrust litigation over generic drug pricing.

CFO transition: Denton (Pfizer) named next CFO of Nike. Dismissed from US states' drug price-fixing lawsuit on generic medications.
-0.48
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
9.3
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
24
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Pfizer is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Merck Novartis FDA AstraZeneca China Middle East CEO PlocamiumAI NYSE Europe London AMD S&P 500 FedEx Nevada
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-28 2026-06-27 24 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.236
Narrative Drift
0.000
Spectral Shift
380.985
Sentiment-Momentum Divergence
0.000
Source Concentration
0.807
Signal
Pfizer is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #41 of 78 in Health Care — in line with sector peers. PSI down 0.15 from yesterday (-0.32 -> -0.48).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
41 of 78
Sector Rank
-0.10
Peer Z-Score
48%
Sector Percentile
Network Analysis
24 Degree Centrality
Ego Network (top connections)
Merck (weight 104.0)Novartis (weight 102.0)FDA (weight 15.0)AstraZeneca (weight 6.0)China (weight 5.0)Middle East (weight 4.0)CEO (weight 4.0)PlocamiumAI (weight 4.0) MerckNovartisFDAAstraZenecaChinaMiddle EastCEOPlocamiumAI Pfizer (degree 24) Pfizer
Centrality History
2026-05-28 2026-06-27 24 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 104 NEW
Novartis 102 NEW
FDA 15 NEW
AstraZeneca 6 NEW
China 5 NEW
Middle East 4 NEW
CEO 4 NEW
PlocamiumAI 4 NEW
NYSE 4 NEW
Europe 3 NEW
London 3 NEW
AMD 3 NEW
S&P 500 3 NEW
FedEx 2 NEW
Nevada 2 NEW
Nvidia 2 NEW
White House 2 NEW
Alphabet 2 NEW
United Airlines 2 NEW
Walmart 2 NEW
Bloomberg 2 NEW
New York 2 NEW
WHO 2 NEW
Novo Nordisk 1 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-27 ← Intelligence Network